WHO wants to test drug derived from Artemisia

As the coronavirus pandemic worsens with the Delta variant, the World Health Organization is not forgetting the treatment trail, even if there are several vaccines. It must be recognized that if treatments are found in addition to vaccines, fighting the pandemic will be even more effective. and several studies with existing drugs will soon be started.

The information was released by WHO Director General Tedros Adhanom Ghebreyesus. Three treatments are being tested: artesunate, imatinib, and infliximab. “Artesunate, a treatment for malaria in its severe form; Imatinib, a medicine used to treat certain types of cancer, and infliximab, a medicine used to treat diseases of the immune system, ”said Ghebreyesus. Artesunate is actually a semi-synthetic derivative of the artemisinin group, which is itself an active ingredient isolated from the Artemisia annua plant. This plant is also the main substance of Covid-Organics used by the Malagasy people.

Covid-Organics of the Malagasy people

Artemisia had been proposed a few months ago by the Madagascan President, who confirmed that this plant was used in the treatment proposed by the country. However, the WHO had called for caution and stated that it was necessary to carry out tests according to international standards. The announcement of the test of a treatment based on Artemisia will therefore allow us to learn more about the effectiveness of this plant against the Covid-19 virus.

View comments

Related Articles

Back to top button